youtube_live
Q3 2026 earnings • released • EPS beat +2,32% • Revenue miss -0,16%
See resultschevron_right
ALC:NYSE
Alcon AG
72,46 USD
arrow_downward
-2,37%(-1,76) 1D
72,46 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 11-ноя., 16:00:03 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
71,70 USD
High
72,54 USD
Low
70,34 USD
Mkt. cap
29,69 млд
Avg. vol.
1,98 млн
Volume
4,76 млн
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 миң
Open
71,70 USD
High
72,54 USD
Low
70,34 USD
Mkt. cap
29,69 млд
Avg. vol.
1,98 млн
Volume
4,76 млн
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 миң
News stories
From web sources and news partners
GuruFocus
·
53 мүнөт мурун
Alcon Inc (ALC) (Q3 2026) Earnings Call Highlights: Solid Sales
Yahoo Finance
·
3 саат мурун
Alcon Stocks Fall 4% After Lens Implant Sales Slip and Guidance Narrows
Benzinga
·
3 саат мурун
Implantable Headwinds Clip Alcon Revenue Pace Despite Solid Premium Lens Gains
Zacks
·
4 саат мурун
ALC's Q3 Earnings Beat, Revenues Miss, '26 Outlook Narrows, Stock Down
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 миң
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorHealth Care
IndustryMedical device
Websitealcon.com